US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Neurizon Therapeutics Ltd (NUZ) 銘柄情報

Neurizon Therapeutics Ltd (NUZ)

0.071

0.001

(1.43%)

終了 7月3日 3:00PM

Neurizon Therapeutics Ltd (NUZ) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.071

( 1.43% )

買値

0.07

売値

0.075

出来高

874,953

0.071 日の範囲 0.075

0.055 52 週間の範囲 0.185

時価総額

前日終値

0.07

始値

0.072

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 722,505

発行済株式数

746,274,115

配当利回り

PER

-1.97

1 株当たり利益 (EPS)

-0.03

歳入

5.98M

純利益

-14.85M

Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.neurizon.com

本社

Melbourne, Australia

設立

2026

Neurizon Therapeutics Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker NUZ. The last closing price for Neurizon Therapeutics was AUD0.07. Over the last year, Neurizon Therapeutics shares have traded in a share price range of AUD 0.055 to AUD 0.185.

Neurizon Therapeutics currently has 746,274,115 shares in issue. The market capitalisation of Neurizon Therapeutics is AUD52.99 million. Neurizon Therapeutics has a price to earnings ratio (PE ratio) of -1.97.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.011	18.3333333333	0.06	0.075	0.058	1862993	0.05992152	DE
4	0.009	14.5161290323	0.062	0.075	0.055	1299918	0.06134903	DE
12	-0.011	-13.4146341463	0.082	0.09	0.055	790431	0.06676858	DE
26	-0.009	-11.25	0.08	0.105	0.055	686974	0.0761902	DE
52	-0.089	-55.625	0.16	0.185	0.055	640441	0.10297299	DE
156	-0.159	-69.1304347826	0.23	0.245	0.055	557828	0.1197896	DE
260	-0.159	-69.1304347826	0.23	0.245	0.055	557828	0.1197896	DE

NUZ - Frequently Asked Questions (FAQ)

What is the current Neurizon Therapeutics Ltd share price?

The current share price of Neurizon Therapeutics Ltd is AUD 0.071

How many Neurizon Therapeutics Ltd shares are in issue?

Neurizon Therapeutics Ltd has 746,274,115 shares in issue

What is the market cap of Neurizon Therapeutics Ltd?

The market capitalisation of Neurizon Therapeutics Ltd is AUD 52.99M

What is the 1 year trading range for Neurizon Therapeutics Ltd share price?

Neurizon Therapeutics Ltd has traded in the range of AUD 0.055 to AUD 0.185 during the past year

What is the PE ratio of Neurizon Therapeutics Ltd?

The price to earnings ratio of Neurizon Therapeutics Ltd is -1.97

What is the cash to sales ratio of Neurizon Therapeutics Ltd?

The cash to sales ratio of Neurizon Therapeutics Ltd is 7.24

What is the registered address of Neurizon Therapeutics Ltd?

The registered address for Neurizon Therapeutics Ltd is Suite 2, Melbourne, Victoria, 3000

What is the Neurizon Therapeutics Ltd website address?

The website address for Neurizon Therapeutics Ltd is www.neurizon.com

Which industry sector does Neurizon Therapeutics Ltd operate in?

Neurizon Therapeutics Ltd operates in the Biotechnology & Life Sciences sector

Seminole Red

Seminole Red 15分前

Ruined VW’s - purist not allowed

Almost positive it’s ruined.

https://www.facebook.com/reel/1768850754281751

Ray_137

Ray_137 18分前

Any news about the date of 30th June 2026?

SkeBallLarry

SkeBallLarry 20分前

% Happy 4th to you, Getmore ~ Thanks 4 All % ..

OliXPharma_Official

OliXPharma_Official 28分前

Global pharma interest in RNAi therapeutics continues to accelerate.

According to BioSpace, AstraZeneca has entered into a collaboration with CSPC Pharmaceutical Group to discover and develop siRNA therapeutics for kidney diseases. The deal is reportedly worth up to $1.77 billion, inc

Pittsburgh Boy

Pittsburgh Boy 28分前

Umm no that's why I asked, thanks

diamondguru-one

diamondguru-one 33分前

On September 30th…

President Trump is set to declare this miracle material a national strategic resource. And ban it as a U.S. expor t.

That means every major tech company on the planet will be forced to come here — to U.S. soil — to get it.

Apple, NVI

sentiment_stocks

sentiment_stocks 59分前

If the mOS of the control arm drops, wouldn’t that increase the difference between the two?

I do wonder if the MAIC was, in the end, simply more conservative due to its weighting than the patient level scoring?

Kool Aid Man

Kool Aid Man 1時間前

Gullible goobers actually believe they'd own Patagroania..smh

BeachBum

BeachBum 1時間前

30 mil, pay attention.

europa7

europa7 1時間前

Europe's MiCA Deadline Leaves Four in Five Crypto Firms Without a Licence
1 July 2026
https://www.sandmark.com/news/features/europes-mica-deadline-leaves-four-five-crypto-firms-without-licence

"...The transitional window closed on 1 Jul, and the grace period that let nat

GseHeist

GseHeist 1時間前

Looks like AL4ZR is playing F2 soccer on the FiFA sidelines. Very very dangerous game he is playing and he doesn't belong here.

nowwhat2

nowwhat2 2時間前

https://investorshub.advfn.com/uimage/uploads/2026/7/3/ljz[qbtc_july_2_10y_10pm_GEE_200_60.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7/3/qbfzqbtc_july_2_1y_200_60k_zoom.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7

along4zride

along4zride 2時間前

He is in a league the garden variety penny pinching stock holder cannot comprehend. There is little empathy for (FNMA) bottom feeders.Never has been and never will be .

sometimes_right

sometimes_right 2時間前

The remaining bank defendants contesting LIBOR multi-billion-dollar appellate battle, along with those that have completely settled out of the primary investor tracks, are detailed below.

The Remaining Banks Involved in the Appeal
The specific financial institutions that did no

ZeroGravitas

ZeroGravitas 2時間前

JFB,
I know a lot of investors B&H QQQ but I think TQQQ is used more by traders. I know some that may go in and out of TQQQ based on the technical indicators for QQQ. I just think that there is a very small universe of investors with the stomach to hold on through a +70% drawdown. AIM will st

firebag1

firebag1 2時間前

Yup this is a 50 bagger in the making imo

firebag1

firebag1 2時間前

Yup. Good post. Lots of eyes will be on this

firebag1

firebag1 2時間前

Huge is all I can say.
I’m extremely bullish on this stock
Best wishes to you all
Happy 4th of July!!
250 big anniversary!!! Lol

Genz2

Genz2 2時間前

https://www.theregister.com/legal/2026/07/02/startup-sues-palo-alto-networks-koi-security-saying-an-ai-hallucinated-report-falsely-linked-it-to-chinese-espionage/5266201

flipper44

flipper44 2時間前

What you are suggesting is impossible. The delta can increase, which might happen, but the patient level data (arm) cannot increase the treatment arm median survival.

Edit: I see someone else already pointed this out to you.

thistraderknowsall

thistraderknowsall 2時間前

BTC TO $125K...NOM Crypto...not in Kansas anymore..MASSIVE short squeeeeeeeeze to $1 underway!!The next RAVE..RUNNER
No brainer.. enjoy the gains!

wronginvestor

wronginvestor 2時間前

Was always just a publicity stunt.

surfer44

surfer44 2時間前

Why Oil Prices Are Diverging from Fundamentals

https://youtu.be/OakeC8zQzJM

flipper44

flipper44 2時間前

Get some sleep everyone. Tomorrow will wait. Market Holiday! You have all weekend to take it in.

GritsWalabe

GritsWalabe 2時間前

Wrapped up a great green week. $SNTX has the share structure you want and multiple revenue generating companies. This company is bound for bigger boards.

Neurizon Therapeutics

Income Asset Management

Sundance Resources

Pepper I Prime 2017 3

Firetail Resources

Smart ABS Series 2016 1

The Food Revolution

European Resources

Powerhouse Ventures

Hyundai Capital Services

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。